• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三种新型竞争性内源性 RNA 生物标志物在肺腺癌中具有预后价值的综合分析。

Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.

机构信息

Department of Gerontology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huai'an, Jiangsu, China.

Department of Endocrinology, Clinical Medical College of Yangzhou University, Yangzhou, Jiangsu, China.

出版信息

Biomed Res Int. 2020 Aug 4;2020:2837906. doi: 10.1155/2020/2837906. eCollection 2020.

DOI:10.1155/2020/2837906
PMID:32802839
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7424383/
Abstract

Increasing evidence has shown competitive endogenous RNAs (ceRNAs) play key roles in numerous cancers. Nevertheless, the ceRNA network that can predict the prognosis of lung adenocarcinoma (LUAD) is still lacking. The aim of the present study was to identify the prognostic value of key ceRNAs in lung tumorigenesis. Differentially expressed (DE) RNAs were identified between LUAD and adjacent normal samples by limma package in R using The Cancer Genome Atlas database (TCGA). Gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway function enrichment analysis was performed using the clusterProfiler package in R. Subsequently, the LUAD ceRNA network was established in three steps based on ceRNA hypothesis. Hub RNAs were identified using degree analysis methods based on Cytoscape plugin cytoHubba. Multivariate Cox regression analysis was implemented to calculate the risk score using the candidate ceRNAs and overall survival information. The survival differences between the high-risk and low-risk ceRNA groups were determined by the Kaplan-Meier and log-rank test using survival and survminer package in R. A total of 2,989 mRNAs, 185 lncRNAs, and 153 miRNAs were identified. GO and KEGG pathway function enrichment analysis showed that DE mRNAs were mainly associated with "sister chromatid segregation," "regulation of angiogenesis," "cell adhesion molecules (CAMs)," "cell cycle," and "ECM-receptor interaction." LUAD-related ceRNA network was constructed, which comprised of 54 nodes and 78 edges. Top ten hub RNAs (hsa-miR-374a-5p, hsa-miR-374b-5p, hsa-miR-340-5p, hsa-miR-377-3p, hsa-miR-21-5p, hsa-miR-326, SNHG1, RALGPS2, and PITX2) were identified according to their degree. Kaplan-Meier survival analyses demonstrated that hsa-miR-21-5p and RALGPS2 had a significant prognostic value. Finally, we found that a high risk of three novel ceRNA interactions (SNHG1-hsa-miR-21-5p-RALGPS2, SNHG1-hsa-miR-326-RALGPS2, and SNHG1-hsa-miR-377-3p-RALGPS2) was positively associated with worse prognosis. Three novel ceRNAs (SNHG1-hsa-miR-21-5p-RALGPS2, SNHG1-hsa-miR-326-RALGPS2, and SNHG1-hsa-miR-377-3p-RALGPS2) might be potential biomarkers for the prognosis and treatment of LUAD.

摘要

越来越多的证据表明,竞争性内源性 RNA(ceRNA)在许多癌症中发挥着关键作用。然而,能够预测肺腺癌(LUAD)预后的 ceRNA 网络仍然缺乏。本研究的目的是确定关键 ceRNA 在肺肿瘤发生中的预后价值。使用 R 中的 limma 包,通过癌症基因组图谱数据库(TCGA),在 LUAD 和相邻正常样本之间鉴定差异表达(DE)RNA。使用 R 中的 clusterProfiler 包对基因本体(GO)和京都基因与基因组百科全书(KEGG)途径功能进行富集分析。随后,基于 ceRNA 假说分三步建立 LUAD ceRNA 网络。使用 Cytoscape 插件 cytoHubba 中的度分析方法鉴定核心 RNA。使用候选 ceRNA 和总生存信息,通过多变量 Cox 回归分析计算风险评分。使用 R 中的 survival 和 survminer 包,通过 Kaplan-Meier 和对数秩检验确定高风险和低风险 ceRNA 组之间的生存差异。

总共鉴定出 2989 个 mRNAs、185 个 lncRNAs 和 153 个 miRNAs。GO 和 KEGG 途径功能富集分析表明,DE mRNAs 主要与“姐妹染色单体分离”、“血管生成调节”、“细胞粘附分子(CAMs)”、“细胞周期”和“ECM-受体相互作用”有关。构建了与 LUAD 相关的 ceRNA 网络,该网络包含 54 个节点和 78 个边缘。根据其度,确定了前 10 个核心 RNA(hsa-miR-374a-5p、hsa-miR-374b-5p、hsa-miR-340-5p、hsa-miR-377-3p、hsa-miR-21-5p、hsa-miR-326、SNHG1、RALGPS2 和 PITX2)。Kaplan-Meier 生存分析表明,hsa-miR-21-5p 和 RALGPS2 具有显著的预后价值。最后,我们发现三个新的 ceRNA 相互作用(SNHG1-hsa-miR-21-5p-RALGPS2、SNHG1-hsa-miR-326-RALGPS2 和 SNHG1-hsa-miR-377-3p-RALGPS2)的高风险与预后不良呈正相关。三个新的 ceRNA(SNHG1-hsa-miR-21-5p-RALGPS2、SNHG1-hsa-miR-326-RALGPS2 和 SNHG1-hsa-miR-377-3p-RALGPS2)可能是 LUAD 预后和治疗的潜在生物标志物。

相似文献

1
Integrative Analysis of Three Novel Competing Endogenous RNA Biomarkers with a Prognostic Value in Lung Adenocarcinoma.三种新型竞争性内源性 RNA 生物标志物在肺腺癌中具有预后价值的综合分析。
Biomed Res Int. 2020 Aug 4;2020:2837906. doi: 10.1155/2020/2837906. eCollection 2020.
2
Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.预测涉及人肺腺癌进展的失调竞争内源性 RNA 特征。
Cancer Biomark. 2020;29(3):399-416. doi: 10.3233/CBM-200133.
3
Identification of a novel prognosis-associated ceRNA network in lung adenocarcinoma via bioinformatics analysis.基于生物信息学分析鉴定肺腺癌中新型预后相关 ceRNA 网络。
Biomed Eng Online. 2021 Nov 24;20(1):117. doi: 10.1186/s12938-021-00952-x.
4
Comprehensive Analysis of Aberrantly Expressed Profiles of lncRNAs and miRNAs with Associated ceRNA Network in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.肺腺癌和肺鳞癌中异常表达的 lncRNAs 和 miRNAs 谱的综合分析及其相关 ceRNA 网络。
Pathol Oncol Res. 2020 Jul;26(3):1935-1945. doi: 10.1007/s12253-019-00780-4. Epub 2020 Jan 2.
5
Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.基于异常 lncRNA-miRNA-mRNA 网络和 Cox 回归模型的肺腺癌预后生物标志物的综合分析。
Biosci Rep. 2020 Jan 31;40(1). doi: 10.1042/BSR20191554.
6
Characterization of a non-coding RNA-associated ceRNA network in metastatic lung adenocarcinoma.转移性肺腺癌中 ncRNA 相关 ceRNA 网络的表征。
J Cell Mol Med. 2020 Oct;24(20):11680-11690. doi: 10.1111/jcmm.15778. Epub 2020 Aug 29.
7
Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.构建并综合分析 ceRNA 网络,揭示肺腺癌潜在的预后生物标志物。
BMC Cancer. 2021 Jul 23;21(1):849. doi: 10.1186/s12885-021-08462-8.
8
Construction and Analysis of Survival-Associated Competing Endogenous RNA Network in Lung Adenocarcinoma.构建并分析肺腺癌中与生存相关的竞争性内源性 RNA 网络。
Biomed Res Int. 2021 Feb 11;2021:4093426. doi: 10.1155/2021/4093426. eCollection 2021.
9
Comprehensive Analysis of Competing Endogenous RNA (ceRNA) Network Based on RNAs Differentially Expressed in Lung Adenocarcinoma Using The Cancer Genome Atlas (TCGA) Database.基于癌症基因组图谱(TCGA)数据库中肺腺癌差异表达 RNA 进行的竞争性内源 RNA(ceRNA)网络综合分析。
Med Sci Monit. 2020 Jun 13;26:e922676. doi: 10.12659/MSM.922676.
10
Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.全面分析 TPX2 相关 ceRNA 网络作为肺腺癌的预后生物标志物。
Int J Med Sci. 2020 Sep 1;17(16):2427-2439. doi: 10.7150/ijms.49053. eCollection 2020.

引用本文的文献

1
Epigenetic Modifications Associated With Wildland-Urban Interface (WUI) Firefighting.与城乡结合部(WUI)灭火相关的表观遗传修饰
Environ Mol Mutagen. 2025 Jan-Feb;66(1-2):22-33. doi: 10.1002/em.70002. Epub 2025 Feb 19.
2
B-cell signatures characterize the immune landscape and predict LUAD prognosis via the integration of scRNA-seq and bulk RNA-seq.B细胞特征通过整合单细胞RNA测序和批量RNA测序来表征免疫格局并预测肺腺癌预后。
Sci Rep. 2025 Feb 14;15(1):5453. doi: 10.1038/s41598-025-89213-8.
3
Novel pyroptosis-related lncRNAs and ceRNAs predict osteosarcoma prognosis and indicate immune microenvironment signatures.

本文引用的文献

1
Pseudogene-Derived lncRNAs and Their miRNA Sponging Mechanism in Human Cancer.假基因衍生的长链非编码RNA及其在人类癌症中的miRNA海绵机制
Front Cell Dev Biol. 2020 Feb 28;8:85. doi: 10.3389/fcell.2020.00085. eCollection 2020.
2
Colorectal cancer statistics, 2020.2020 年结直肠癌统计数据。
CA Cancer J Clin. 2020 May;70(3):145-164. doi: 10.3322/caac.21601. Epub 2020 Mar 5.
3
Construction of a competing endogenous RNA network using differentially expressed lncRNAs, miRNAs and mRNAs in non‑small cell lung cancer.构建竞争性内源性 RNA 网络,使用非小细胞肺癌中差异表达的 lncRNA、miRNA 和 mRNA。
新型焦亡相关长链非编码RNA和竞争性内源RNA预测骨肉瘤预后并指示免疫微环境特征
Heliyon. 2023 Oct 31;9(11):e21503. doi: 10.1016/j.heliyon.2023.e21503. eCollection 2023 Nov.
4
A Pilot Analysis of Circulating cfRNA Transcripts for the Detection of Lung Cancer.用于检测肺癌的循环游离RNA转录本的初步分析
Diagnostics (Basel). 2022 Nov 22;12(12):2897. doi: 10.3390/diagnostics12122897.
5
Identification of as a Potential Oncogene of Invasive Metastasis and Proliferation in PDAC.鉴定其为胰腺导管腺癌侵袭转移和增殖的潜在癌基因。
Front Cell Dev Biol. 2022 Feb 14;10:762372. doi: 10.3389/fcell.2022.762372. eCollection 2022.
6
Identification of Ferroptosis-Related Genes Signature Predicting the Efficiency of Invasion and Metastasis Ability in Colon Adenocarcinoma.鉴定预测结肠腺癌侵袭和转移能力的铁死亡相关基因特征
Front Cell Dev Biol. 2022 Jan 26;9:815104. doi: 10.3389/fcell.2021.815104. eCollection 2021.
7
Depleting hsa_circ_0000567 suppresses acquired gefitinib resistance and proliferation of lung adenocarcinoma cells through regulating the miR-377-3p / ZFX axis: an in vitro and in vivo study.通过调控miR-377-3p/ZFX轴耗尽hsa_circ_0000567可抑制肺腺癌细胞获得性吉非替尼耐药性及增殖:一项体内外研究
Histol Histopathol. 2022 Jul;37(7):637-654. doi: 10.14670/HH-18-431. Epub 2022 Feb 8.
8
MiR-133b suppresses the proliferation, migration and invasion of lung adenocarcinoma cells by targeting SKA3.miR-133b 通过靶向 SKA3 抑制肺腺癌细胞的增殖、迁移和侵袭。
Cancer Biol Ther. 2021 Dec 2;22(10-12):571-578. doi: 10.1080/15384047.2021.1973819. Epub 2021 Oct 28.
9
Overexpression of microRNA-340-5p Ameliorates Inflammatory Response and Intracellular Survival of in Alveolar Type II Cells.微小RNA-340-5p的过表达改善肺泡II型细胞中的炎症反应和细胞内存活。
Infect Drug Resist. 2021 Apr 21;14:1573-1584. doi: 10.2147/IDR.S291867. eCollection 2021.
10
Expression and gene regulatory network of SNHG1 in hepatocellular carcinoma.SNHG1 在肝细胞癌中的表达及基因调控网络。
BMC Med Genomics. 2021 Jan 26;14(1):28. doi: 10.1186/s12920-021-00878-2.
Oncol Rep. 2019 Dec;42(6):2402-2415. doi: 10.3892/or.2019.7378. Epub 2019 Oct 17.
4
SNHG1 contributes to proliferation and invasion by regulating miR-382 in breast cancer.SNHG1通过调控miR-382促进乳腺癌的增殖和侵袭。
Cancer Manag Res. 2019 Jun 18;11:5589-5598. doi: 10.2147/CMAR.S198624. eCollection 2019.
5
Long non-coding RNA SNHG1 functions as a competitive endogenous RNA to regulate PDCD4 expression by sponging miR-195-5p in hepatocellular carcinoma.长链非编码 RNA SNHG1 通过海绵吸附 miR-195-5p 来调节肝细胞癌中 PDCD4 的表达,作为竞争性内源性 RNA 发挥作用。
Gene. 2019 Sep 25;714:143994. doi: 10.1016/j.gene.2019.143994. Epub 2019 Jul 19.
6
Expression level and clinical significance of SNHG1 in human cancers: a meta-analysis.SNHG1在人类癌症中的表达水平及临床意义:一项荟萃分析
Onco Targets Ther. 2019 Apr 24;12:3119-3127. doi: 10.2147/OTT.S184803. eCollection 2019.
7
Integrated analysis reveals five potential ceRNA biomarkers in human lung adenocarcinoma.综合分析揭示了人类肺腺癌中的五种潜在竞争性内源性RNA生物标志物。
PeerJ. 2019 Apr 29;7:e6694. doi: 10.7717/peerj.6694. eCollection 2019.
8
A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer.一种与胰腺癌预后相关的新型信使核糖核酸-微小核糖核酸-长链非编码核糖核酸竞争性内源核糖核酸三联子网络
Aging (Albany NY). 2019 May 6;11(9):2610-2627. doi: 10.18632/aging.101933.
9
LncRNA SNHG1 promotes liver cancer development through inhibiting p53 expression via binding to DNMT1.长链非编码 RNA SNHG1 通过与 DNMT1 结合抑制 p53 表达促进肝癌的发展。
Eur Rev Med Pharmacol Sci. 2019 Apr;23(7):2768-2776. doi: 10.26355/eurrev_201904_17550.
10
Long non-coding SNHG1 in cancer.长链非编码 SNHG1 在癌症中的作用。
Clin Chim Acta. 2019 Jul;494:38-47. doi: 10.1016/j.cca.2019.03.002. Epub 2019 Mar 6.